Company intelligence / Profile preview

Invicro

Boston, Massachusetts, United Stateslp.invicro.com ↗

Ownership: Private
Development stage: Commercial

Overview

Invicro provides advanced imaging biomarkers, quantitative pathology/genomics services, and software platforms to accelerate drug discovery and development. Their solutions are used by leading pharmaceutical companies across multiple therapeutic areas. They do not have their own clinical pipeline but enable the success of client programs with cutting-edge informatics tools like VivoQuant® and iPACS®. The company has supported thousands of studies globally.

Therapeutic areas: PulmonologyCardiovascularMetabolic DisordersRheumatologyOncologyNeurology
Modalities: Imaging biomarker analysisAdvanced analytics and AI-based image analysisQuantitative pathology and genomics services
Industry: Drug Discovery Services

Partnerships

Accenture INTIENT Network partnercollaborations with top pharmaceutical companies (>50% of top pharma use their products)academic partnerships globally

Beyond the preview

Go deeper on Invicro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invicro.

Explore the full profile